Related Experiment Videos
Insights
Valproic acid effectively controlled seizures in children with epilepsy, improving control by 82% and enhancing alertness. Careful monitoring is crucial due to potential side effects and drug interactions.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
Background:
- Epilepsy is a common neurological disorder in children.
- Effective seizure control and management of associated comorbidities are critical.
- Valproic acid is a widely used anticonvulsant, but its efficacy and safety profile in pediatric populations require ongoing evaluation.
Purpose of the Study:
- To evaluate the efficacy of valproic acid in improving seizure control in children with epilepsy.
- To assess the impact of valproic acid on alertness and behavior in pediatric patients.
- To document the incidence and nature of adverse effects associated with valproic acid treatment in children.
Main Methods:
- A cohort of 100 children with epilepsy received valproic acid, either as monotherapy or in combination with other anticonvulsants.
- Seizure control was assessed across different age groups and seizure types.
- Adverse events, including laboratory abnormalities and clinical side effects, were systematically recorded.
Main Results:
- Valproic acid demonstrated significant seizure control improvement, averaging 82%, across all pediatric age groups.
- Petit mal seizures showed the best response, but other seizure types, including those in children with cognitive impairments, also improved.
- Improvements in alertness and behavior were frequently observed alongside seizure control.
- Common transient side effects included leukopenia (27%) and elevated SGOT (44%).
- Less frequent adverse events included alopecia, gastrointestinal distress, pancreatitis, thrombocytopenia, edema, and coma.
- Three deaths occurred in severely impaired children, though causality with valproic acid remains unclear.
Conclusions:
- Valproic acid is an effective treatment for improving seizure control in children with epilepsy, with benefits extending to behavior and alertness.
- While generally well-tolerated, careful monitoring for potential toxic effects and drug interactions is essential during treatment.
- The study highlights the need for vigilant patient management to optimize therapeutic outcomes and mitigate risks in pediatric epilepsy care.
Abstract:
Valproic acid, used alone or in combination with other anticonvulsants in 100 children with epilepsy, improved seizure control in all age groups. Mean improvement in seizure control was 82%. Petit mal seizures responded best, but other types of seizures, even with associated mental and physical handicaps, also responded well. A substantial improvement in alertness and behavior often occurred. Leukopenia (27%) and an elevated SGOT value (44%) were frequent but transient. Other side effects included alopecia (1), gastrointestinal distress with vomiting (7), pancreatitis (1), thrombocytopenia (1), edema (2), and coma (2). Three severely retarded children with frequent seizures died while receiving valproic acid, but it is not clear that death was caused by valproic acid. Children must be monitored carefully for potential toxic effects, and drug interactions with other anticonvulsants may cause problems in treatment.